首页> 外文OA文献 >Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
【2h】

Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach

机译:Bacopa Monnieri及其生物活性化合物推断出神经疾病的多目标治疗策略:化学信息学和系统药理学方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neurological diseases (NDs), especially Alzheimer’s and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurvedic medicine used to combat the complex diseases from a holistic and integrative point of view has shown efficiency and effectiveness in the treatment of NDs. Bacopa monnieri is a potent Indian medicinal herb used for multiple ailments, but is significantly known as a nootropic or brain tonic and memory enhancer. This annual herb has various active compounds and acts as an alternative and complementary medicine in various countries. However, system-level insights of the molecular mechanism of a multiscale treatment strategy for NDs is still a bottleneck. Considering its prominence, we used cheminformatics and system pharmacological approaches, with the aim to unravel the various molecular mechanisms represented by Bacopa-derived compounds in identifying the active human targets when treating NDs. First, using cheminformatics analysis combined with the drug target mining process, 52 active compounds and their corresponding 780 direct receptors were retrieved and computationally validated. Based on the molecular properties, bioactive scores and comparative analysis with commercially available drugs, novel and active compounds such as asiatic acid (ASTA) and loliolide (LLD) to treat the Alzheimer’s and SCA were identified. According to the interactions among the active compounds, the targets and diseases were further analyzed to decipher the deeper pharmacological actions of the drug. NDs consist of complex regulatory modules that are integrated to dissect the therapeutic effects of compounds derived from Bacopa in various pathological features and their encoding biological processes. All these revealed that Bacopa compounds have several curative activities in regulating the various biological processes of NDs and also pave the way for the treatment of various diseases in modern medicine.
机译:神经系统疾病(NDS),特别是阿尔茨海默氏病和脊髓小脑性共济失调(SCA),可以引起严重的大脑生化异常,脊髓和人类的其它神经。不断增加的患病率已经导致了对新药研发的需要。用于从一个全面的和综合点打击复杂疾病印度传统和阿育吠陀医学已显示出ND的处理效率和有效性。假马齿苋是用于多个疾病的强效印度草药,但显著称为益智或大脑强直和记忆增强剂。这一年生草本植物具有多种活性化合物并作为在不同国家的替代和补充药物。然而,为NDS多尺度治疗策略的分子机制的系统级见解仍然是一个瓶颈。考虑到它的突出,我们使用化学信息和系统药理学方法,目的解开由假马齿苋衍生的化合物为代表的各种分子机制治疗的ND时识别所述活性的人的目标。首先,使用化学信息分析与药物目标挖掘过程相结合,被检索52种活性化合物和它们的对应的780个直接受体和计算验证。基于分子性质,生物活性分数和与市售的药物,新颖的和活性化合物如积雪草酸(ASTA)和loliolide(LLD)的比较分析来治疗阿尔茨海默氏症和SCA进行鉴定。根据活性化合物之间的相互作用,进一步分析的对象和疾病破译药物的更深的药理作用。的ND包括被集成到解剖从假马齿苋在各种病理特征和它们的编码生物过程衍生的化合物的治疗效果复杂的管理模块。所有这些表明,假马齿苋化合物具有调节ND的各种生物过程的几个治疗活动,也铺平了现代医学的治疗各种疾病的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号